Literature DB >> 29596563

Error in Abstract and Tables.

.   

Abstract

Year:  2018        PMID： 29596563      PMCID： PMC8177394          DOI： 10.1001/jamaophthalmol.2018.0795

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  1 in total

1.  Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Neil M Bressler; Wesley T Beaulieu; Adam R Glassman; Kevin J Blinder; Susan B Bressler; Lee M Jampol; Michele Melia; John A Wells
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.